GeneDx Holdings is facing a securities class action lawsuit following a 49% single-day crash in its stock price in May 2026. The decline is linked to a 94% write-off of assets associated with the acquisition of Fabric Genomics and poor Q1 2026 financial results. The lawsuit follows a significant drop in share value, which fell by $33.42 during the period in question.
